Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at apitolisib with everolimus for kidney cancer that has spread (ROVER)

Overview

Cancer types:

Kidney cancer, Renal cell cancer, Secondary cancers

Status:

Results

Phase:

Phase 2

Details

This trial compared apitolisib and everolimus for kidney cancer that had spread to another part of the body. It was for people with renal cell cancer (RCC).

The trial was open for people to join between 2011 and 2012. The team published the results in 2016.

Recruitment start: 1 October 2011

Recruitment end: 30 July 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Thomas Powles

Supported by

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Roche-Genentech

Last reviewed: 6 July 2023

CRUK internal database number: 8876

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.